BPC-157, also known as Body Protection Compound-157, is a synthetic peptide derived from a partial sequence of a naturally occurring protein found in gastric juice
Finally, at the moment of writing, one human clinical study reported that patients with lung cancer and T2D showed a significantly improved prognosis when cotreated with a combination of sodium-glucose cotransporter 2 inhibitors and GLP-1RAs (68)
Q: What is BPC-157 commonly used to study
In the following review article, we aim at reviewing the evidence related to the impact of GLP-1 RAs, on gastrointestinal procedures, mainly EGDs and colonoscopies, and their implications on the peri-operative period
Neque porro quisquam est qui dolorem ipsum quia dolor sit amet Lorem ipsum dolor sit amet, consectetur adipiscing elit
139 PompeianoM.CirelliC.Ronca-TestoniS.TononiG